Mortara Instrument
 | This article reads like a press release or a news article and may be largely based on routine coverage. (June 2025) |
| Industry | Medical device manufacturer |
|---|---|
| Founded | 1982, in Milwaukee, Wisconsin |
| Founder | David W. Mortara |
| Fate | Acquired by Hill-Rom Holdings in 2017 |
| Products | Electrophysiological diagnostics devices in cardiology (Electrocardiographs, etc) |
Mortara Instrument was a privately held, U.S.-based medical technology company specializing in the design, development, and manufacture of diagnostic cardiology and patient monitoring solutions. Founded in 1982 by David W. Mortara, in Milwaukee, Wisconsin, the company became a leader in electrocardiography (ECG) equipment and related technologies.[1] Mortara Instrument was acquired by Hill-Rom Holdings, Inc. in 2017 for $330 million in cash, to be later run from the Welch Allyn franchise.[2][3][4][5]
History
[edit]Mortara Instrument was established in 1982 by David W. Mortara, a physicist and former vice president of engineering at Marquette Electronics, which was later acquired by GE Healthcare.[6] Initially, the company manufactured medical devices for Marquette Electronics and other firms. Over time, it transitioned to producing its own branded ECG devices, overcoming challenges in competing with larger companies like GE Healthcare and Philips in North America.[7][4][5][3]
By 2000, Mortara Instrument had achieved significant growth, with revenue increasing five-fold from 2000 to 2016, reaching approximately $115 million in 2016. The company employed over 400 people globally and operated a 63,000-square-foot headquarters in Milwaukee's Bradley Woods Business Park, alongside a 64,000-square-foot manufacturing and distribution facility completed in 2016.[8]
In 2004, Mortara in collaboration with the U.S. Food and Drug Administration to create a Digital ECG Warehouse for research purposes to analyze treatment groups.[9][10][11][12]
In 2013, Mortara Instrument acquired the Quinton and Burdick brands from Opko's Cardiac Science, expanding its portfolio of diagnostic cardiology devices. The company focused on innovation, including advanced diagnostic algorithms and electronic medical record (EMR) connectivity.[13][14][15]
On January 10, 2017, Hill-Rom Holdings, Inc., announced a definitive agreement to acquire Mortara Instrument for $330 million in cash, with a tax benefit reducing the effective purchase price to approximately $290 million. The acquisition was completed on February 14, 2017, and Mortara's operations were integrated into Hill-Rom's Front Line Care division, alongside the Welch Allyn franchise, which Hill-Rom had acquired in 2015.[2][16]
References
[edit]- ^ Macfarlane, Peter W.; Kennedy, Julie (2021-09-23). "Automated ECG Interpretation—A Brief History from High Expectations to Deepest Networks". Hearts. 2 (4): 433–448. doi:10.3390/hearts2040034. ISSN 2673-3846.
- ^ a b Inc, Hill-Rom Holdings. "Hill-Rom To Acquire Mortara Instrument, Inc., A Leader In Diagnostic Cardiology And Patient Monitoring Technology". www.prnewswire.com (Press release). Retrieved 2025-06-03.
{{cite press release}}:|last=has generic name (help) - ^ a b Boulton, Guy. "Mortara Instrument to be sold". Journal Sentinel. Retrieved 2025-06-03.
- ^ a b "David Mortara: Department of Physics and Astronomy: Purdue University". www.physics.purdue.edu. Retrieved 2025-06-03.
- ^ a b "Landmark Gift Establishes Center to Improve Monitoring, Address Alarm Fatigue". UCSF School of Nursing. Retrieved 2025-06-03.
- ^ Communications, Grainger Engineering Office of Marketing and. "David Mortara". grainger.illinois.edu. Retrieved 2025-06-03.
- ^ "Where Are They Now?". www.aps.org. Retrieved 2025-06-03.
- ^ "Hill-Rom Pays $330 Milion Cash for Mortara, a Leader in Diagnostic Cardiology and Patient Monitoring Technology". BioSpace. 2017-01-10. Retrieved 2025-06-03.
- ^ Turner, J. Rick; Durham, Todd A. (2008-11-26). Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance. John Wiley & Sons. ISBN 978-0-470-41128-5.
- ^ "The World Leader in ECG Technology". www.mortara.com. Archived from the original on 2003-11-21. Retrieved 2025-06-03.
- ^ "A Practical Approach to Cardiac Safety". Supplements-10-02-2005. 0. 2005-10-02.
{{cite journal}}: Cite journal requires|journal=(help) - ^ Green, Cynthia L. (2019-11-01). "Research implications of the FDA ECG warehouse and related resources". Journal of Electrocardiology. 57: S27 – S33. doi:10.1016/j.jelectrocard.2019.09.009. ISSN 0022-0736.
- ^ admin (2013-04-02). "Cardiac Science Sells Diagnostic Cardiology Product Line to Mortara Instrument". DAIC. Retrieved 2025-06-03.
- ^ Perriello, Brad (2017-01-10). "Hill-Rom to pay $330m for Mortara Instrument". MassDevice. Retrieved 2025-06-03.
- ^ Science, Cardiac. "Cardiac Science announces definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc". www.prnewswire.com (Press release). Retrieved 2025-06-03.
- ^ "David W. Mortara Donates $25 Million to UCSF School of Nursing | UC San Francisco". www.ucsf.edu. 2017-10-27. Retrieved 2025-06-03.